Cited by 248Probiotics and Fermented FoodsReproductive tract infections researchAntifungal resistance and susceptibility

Probiotics for prevention of recurrent vulvovaginal candidiasis: a review

Falagas, M. E.·2006·Journal of Antimicrobial Chemotherapy

Abstract

Vulvovaginal candidiasis (VVC) is a common infection affecting the quality of life of many women. Probiotics have been investigated as possible agents for the prevention of recurrences of VVC. We reviewed the available literature. In some studies the development of VVC was associated with either a low number of lactobacilli in the vagina or with the presence of H2O2-non-producing vaginal lactobacilli, although there are a few studies not supporting these statements. In addition, in vitro studies have shown that lactobacilli can inhibit the growth of Candida albicans and/or its adherence on the vaginal epithelium. The results of some clinical trials support the effectiveness of lactobacilli, especially Lactobacillus acidophilus, Lactobacillus rhamnosus GR-1 and Lactobacillus fermentum RC-14, administered either orally or intravaginally in colonizing the vagina and/or preventing the colonization and infection of the vagina by C. albicans, while the results of a small number of clinical trials do not corroborate these findings. Nevertheless, most of the relevant clinical trials had methodological problems such as small sample size, no control group (placebo) and included women without confirmed recurrent VVC, and thus they are not reliable for drawing definitive conclusions. Thus, the available evidence for the use of probiotics for prevention of recurrent VVC is limited. However, the empirical use of probiotics may be considered in women with frequent recurrence of VVC (more than three episodes per year), especially for those who have adverse effects from or contraindications for the use of antifungal agents, since adverse effects of probiotics are very rare. In any case women should be clearly informed about the unproven usefulness of probiotics for this purpose. In conclusion, despite the promising results of some studies, further research is needed to prove the effectiveness of probiotics in preventing the recurrences of VVC and to allow their wide use for this indication.

Integrity signals

Registry

Crossref · 10.1093/jac/dkl246

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Candida albicans interacts with several bacterial species found in the gut, such as Enterococcus and Escherichia species; those found in the vagina, such as Lactobacillus species; and those found in the lungs of patients with cystic fibrosis, such as Pseudomonas aeruginosa.

    “C. albicans also interacts with several bacterial species found in the gut, such as Enterococcus and Escherichia species; those found in the vagina, such as Lactobacillus species; and those found in the lungs of patients with cystic fibrosis, such as Pseudomonas aeruginosa (13, 34, 54, 78).”

    From <i>Candida albicans</i> Biofilms and Human Disease (2015) · cites this paper as [54]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Falagas, M. E.
Affiliations
Tufts University (US)
Corresponding author
Falagas, M. E.
Venue
Journal of Antimicrobial Chemotherapy
Published
2006-05-30
Volume
58
Issue
2
Pages
266-272
ISSN
  • 0305-7453 (ISSN-L)
  • 1460-2091
OpenAlex
W2100702091
Cited by
248
References
43
Citations by year
2026: 2 · 2025: 9 · 2024: 10 · 2023: 7 · 2022: 14 · 2021: 14 · 2020: 7 · 2019: 15 · 2018: 15 · 2017: 18 · 2016: 15 · 2015: 24 · 2014: 10 · 2013: 13 · 2012: 18
FWCI
1.31
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Antimicrobial Chemotherapy (publishedVersion)
  • PubMed (publishedVersion)
  • HighWire Press Open Archive (submittedVersion)
Topics
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
  • Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
Keywords
probiotics, recurrent vulvovaginal candidiasis, vaginal lactobacilli, Lactobacillus acidophilus, Lactobacillus rhamnosus GR-1, Candida albicans, vaginal colonization
MeSH terms
Antibiosis, Candida albicans, Candidiasis, Vulvovaginal, Female, Humans, Lactobacillus, Vagina, Probiotics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review